Affiliations 

  • 1 Department of Gastroenterology, German Institute of Human Nutrition, Potsdam, Germany
  • 2 Norwich Medical School, Department of Medicine, University of East Anglia, Norwich, UK
  • 3 Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, UK
  • 4 Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
  • 5 Department of Clinical Epidemiology, University of Aarhus, Aarhus, Denmark
  • 6 Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Centre, Florence, Italy
  • 7 Institut National de la Santé et de la Recherche Médicale, Unité XR-290, ISTNA-CNAM, Paris, France
  • 8 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
  • 9 Division of Clinical Epidemiology, DKFZ-German Cancer Research Centre, Heidelberg, Germany
  • 10 Division of Epidemiology, Imperial College London, London, UK
Eur J Clin Nutr, 2017 04;71(4):512-518.
PMID: 28120853 DOI: 10.1038/ejcn.2016.271

Abstract

BACKGROUND/OBJECTIVES: The role of long-term alcohol consumption for the risk of developing ulcerative colitis (UC) and Crohn's disease (CD) is unclear. For the first time, to prospectively assess the role of pre-disease alcohol consumption on the risk of developing UC or CD.

SUBJECTS/METHODS: Nested within the European Prospective Investigation into Cancer and Nutrition (EPIC-IBD), incident UC and CD cases and matched controls where included. At recruitment, participants completed validated food frequency and lifestyle questionnaires. Alcohol consumption was classified as either: non-use, former, light (⩽0.5 and 1 drink per week), below the recommended limits (BRL) (⩽1 and 2 drinks per day), moderate (⩽2.5 and 5 drinks per day), or heavy use (>2.5 and >5 drinks per day) for women and men, respectively; and was expressed as consumption at enrolment and during lifetime. Conditional logistic regression was applied adjusting for smoking and education, taking light users as the reference.

RESULTS: Out of 262 451 participants in six countries, 198 UC incident cases/792 controls and 84 CD cases/336 controls were included. At enrolment, 8%/27%/32%/23%/11% UC cases and 7%/29%/40%/19%/5% CD cases were: non-users, light, BRL, moderate and heavy users, respectively. The corresponding figures for lifetime non-use, former, light, BRL, moderate and heavy use were: 3%/5%/23%/44%/19%/6% and 5%/2%/25%/44%/23%/1% for UC and CD cases, respectively. There were no associations between any categories of alcohol consumption and risk of UC or CD in the unadjusted and adjusted odds ratios.

CONCLUSION: There was no evidence of associations between alcohol use and the odds of developing either UC or CD.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.